Search

Your search keyword '"Finke, Jürgen"' showing total 1,587 results
Start Over Author "Finke, Jürgen"

Refine your results

1,587 results on '"Finke, Jürgen"'

102. Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT

Author

Hernandez-Boluda, Juan Carlos, primary, Eikema, Diderik-Jan, additional, Koster, Linda, additional, Kroeger, Nicolaus, additional, Robin, Marie, additional, de Witte, Moniek, additional, Finke, Jürgen, additional, Finazzi, Maria Chiara, additional, Broers, Annoek, additional, Raida, Luděk, additional, Schaap, Nicolaas, additional, Chiusolo, Patrizia, additional, Verbeek, Mareike, additional, Hazenberg, Carin, additional, Hałaburda, Kazimierz, additional, Kulagin, Alexander, additional, labussiere, helene, additional, Gedde-Dahl, Tobias, additional, Rabitsch, Werner, additional, Raj, Kavita, additional, Drozd-Sokołowska, Joanna, additional, Battipaglia, Giorgia, additional, Polverelli, Nicola, additional, Czerw, Tomasz, additional, Yakoub-Agha, Ibrahim, additional, and McLornan, Donal, additional

Published
2023
Full Text
View/download PDF

103. Supplementary Table from Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: An ALWP/EBMT Analysis

Author

Nagler, Arnon, primary, Ngoya, Maud, primary, Galimard, Jacques-Emmanuel, primary, Labopin, Myriam, primary, Bornhäuser, Martin, primary, Stelljes, Matthias, primary, Finke, Jürgen, primary, Ganser, Arnold, primary, Einsele, Herman, primary, Kröger, Nicolaus, primary, Brecht, Arne, primary, Bethge, Wolfgang, primary, Edinger, Matthias, primary, Kulagin, Aleksandr, primary, Passweg, Jakob, primary, Blau, Igor Wolfgang, primary, Elmaagacli, Ahmet, primary, Schäfer-Eckart, Kerstin, primary, Platzbecker, Uwe, primary, Schroeder, Thomas, primary, Bunjes, Donald, primary, Tischer, Johanna, primary, Martin, Sonja, primary, Spyridonidis, Alexandros, primary, Giebel, Sebastian, primary, Savani, Bipin, primary, and Mohty, Mohamad, primary

Published
2023
Full Text
View/download PDF

104. Data from Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: An ALWP/EBMT Analysis

Author

Nagler, Arnon, primary, Ngoya, Maud, primary, Galimard, Jacques-Emmanuel, primary, Labopin, Myriam, primary, Bornhäuser, Martin, primary, Stelljes, Matthias, primary, Finke, Jürgen, primary, Ganser, Arnold, primary, Einsele, Herman, primary, Kröger, Nicolaus, primary, Brecht, Arne, primary, Bethge, Wolfgang, primary, Edinger, Matthias, primary, Kulagin, Aleksandr, primary, Passweg, Jakob, primary, Blau, Igor Wolfgang, primary, Elmaagacli, Ahmet, primary, Schäfer-Eckart, Kerstin, primary, Platzbecker, Uwe, primary, Schroeder, Thomas, primary, Bunjes, Donald, primary, Tischer, Johanna, primary, Martin, Sonja, primary, Spyridonidis, Alexandros, primary, Giebel, Sebastian, primary, Savani, Bipin, primary, and Mohty, Mohamad, primary

Published
2023
Full Text
View/download PDF

105. Supplementary Data from Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: An ALWP/EBMT Analysis

Author

Nagler, Arnon, primary, Ngoya, Maud, primary, Galimard, Jacques-Emmanuel, primary, Labopin, Myriam, primary, Bornhäuser, Martin, primary, Stelljes, Matthias, primary, Finke, Jürgen, primary, Ganser, Arnold, primary, Einsele, Herman, primary, Kröger, Nicolaus, primary, Brecht, Arne, primary, Bethge, Wolfgang, primary, Edinger, Matthias, primary, Kulagin, Aleksandr, primary, Passweg, Jakob, primary, Blau, Igor Wolfgang, primary, Elmaagacli, Ahmet, primary, Schäfer-Eckart, Kerstin, primary, Platzbecker, Uwe, primary, Schroeder, Thomas, primary, Bunjes, Donald, primary, Tischer, Johanna, primary, Martin, Sonja, primary, Spyridonidis, Alexandros, primary, Giebel, Sebastian, primary, Savani, Bipin, primary, and Mohty, Mohamad, primary

Published
2023
Full Text
View/download PDF

106. Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT

Author

Kröger, Nicolaus, Sbianchi, Giulia, Sirait, Tiarlan, Wolschke, Christine, Beelen, Dietrich, Passweg, Jakob, Robin, Marie, Vrhovac, Radovan, Helbig, Grzegorz, Sockel, Katja, Conneally, Eibhlin, Rubio, Marie Thérèse, Beguin, Yves, Finke, Jürgen, Bernasconi, Paolo, Morozova, Elena, Clausen, Johannes, von dem Borne, Peter, Schaap, Nicolaas, Schroyens, Wilfried, Patriarca, Francesca, Di Renzo, Nicola, Yeğin, Zeynep Arzu, Hayden, Patrick, McLornan, Donal, and Yakoub-Agha, Ibrahim

Abstract

JAK1/2 inhibitor ruxolitinib (RUX) is approved in patients with myelofibrosis but the impact of pretreatment with RUX on outcome after allogeneic hematopoietic stem cell transplantation (HSCT) remains to be determined. We evaluated the impact of RUX on outcome in 551 myelofibrosis patients who received HSCT without (n= 274) or with (n= 277) RUX pretreatment. The overall leukocyte engraftment on day 45 was 92% and significantly higher in RUX responsive patients than those who had no or lost response to RUX (94% vs. 85%, p= 0.05). The 1-year non-relapse mortality was 22% without significant difference between the arms. In a multivariate analysis (MVA) RUX pretreated patients with ongoing spleen response at transplant had a significantly lower risk of relapse (8.1% vs. 19.1%; p= 0.04)] and better 2-year event-free survival (68.9% vs. 53.7%; p= 0.02) in comparison to patients without RUX pretreatment. For overall survival the only significant factors were age > 58 years (p= 0.03) and HLA mismatch donor (p= 0.001). RUX prior to HSCT did not negatively impact outcome after transplantation and patients with ongoing spleen response at time of transplantation had best outcome.

Published
2024
Full Text
View/download PDF

108. Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

Author

de Witte, Theo, Bowen, David, Robin, Marie, Malcovati, Luca, Niederwieser, Dietger, Yakoub-Agha, Ibrahim, Mufti, Ghulam J., Fenaux, Pierre, Sanz, Guillermo, Martino, Rodrigo, Alessandrino, Emilio Paolo, Onida, Francesco, Symeonidis, Argiris, Passweg, Jakob, Kobbe, Guido, Ganser, Arnold, Platzbecker, Uwe, Finke, Jürgen, van Gelder, Michel, van de Loosdrecht, Arjan A., Ljungman, Per, Stauder, Reinhard, Volin, Liisa, Deeg, H.Joachim, Cutler, Corey, Saber, Wael, Champlin, Richard, Giralt, Sergio, Anasetti, Claudio, and Kröger, Nicolaus

Published
2017
Full Text
View/download PDF

109. Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT

Author

Heidenreich, Silke, Ziagkos, Dimitris, de Wreede, Liesbeth C., van Biezen, Anja, Finke, Jürgen, Platzbecker, Uwe, Niederwieser, Dietger, Einsele, Hermann, Bethge, Wolfgang, Schleuning, Michael, Beelen, Dietrich W., Tischer, Johanna, Nagler, Arnon, Glass, Bertram, Maertens, Johan, Yáñez, Lucrecia, Beguin, Yves, Sill, Heinz, Scheid, Christof, Stelljes, Matthias, Ganser, Arnold, Zachée, Pierre, Selleslag, Dominik, de Witte, Theo, Robin, Marie, and Kröger, Nicolaus

Published
2017
Full Text
View/download PDF

111. Feasibility and Outcomes of a Third Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Author

Rank, Andreas, Peczynski, Christophe, Labopin, Myriam, Stelljes, Matthias, Simand, Celestine, Helbig, Grzegorz, Finke, Jürgen, Santarone, Stella, Tischer, Johanna, Lange, Andrzej, Mistrik, Martin, Houhou, Mohamed, Schmid, Christoph, Nagler, Arnon, and Mohty, Mohamad

Published
2021
Full Text
View/download PDF

112. Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Author

Mathew, Nimitha R, Baumgartner, Francis, Braun, Lukas, O'Sullivan, David, Thomas, Simone, Waterhouse, Miguel, Müller, Tony A, Hanke, Kathrin, Taromi, Sanaz, Apostolova, Petya, Illert, Anna L, Melchinger, Wolfgang, Duquesne, Sandra, Schmitt-Graeff, Annette, Osswald, Lena, Yan, Kai-Li, Weber, Arnim, Tugues, Sonia, Spath, Sabine, Pfeifer, Dietmar, Follo, Marie, Claus, Rainer, Lübbert, Michael, Rummelt, Christoph, Bertz, Hartmut, Wäsch, Ralph, Haag, Johanna, Schmidts, Andrea, Schultheiss, Michael, Bettinger, Dominik, Thimme, Robert, Ullrich, Evelyn, Tanriver, Yakup, Vuong, Giang Lam, Arnold, Renate, Hemmati, Philipp, Wolf, Dominik, Ditschkowski, Markus, Jilg, Cordula, Wilhelm, Konrad, Leiber, Christian, Gerull, Sabine, Halter, Jörg, Lengerke, Claudia, Pabst, Thomas, Schroeder, Thomas, Kobbe, Guido, Rösler, Wolf, Doostkam, Soroush, Meckel, Stephan, Stabla, Kathleen, Metzelder, Stephan K, Halbach, Sebastian, Brummer, Tilman, Hu, Zehan, Dengjel, Joern, Hackanson, Björn, Schmid, Christoph, Holtick, Udo, Scheid, Christof, Spyridonidis, Alexandros, Stölzel, Friedrich, Ordemann, Rainer, Müller, Lutz P, Sicre-de-Fontbrune, Flore, Ihorst, Gabriele, Kuball, Jürgen, Ehlert, Jan E, Feger, Daniel, Wagner, Eva-Maria, Cahn, Jean-Yves, Schnell, Jacqueline, Kuchenbauer, Florian, Bunjes, Donald, Chakraverty, Ronjon, Richardson, Simon, Gill, Saar, Kröger, Nicolaus, Ayuk, Francis, Vago, Luca, Ciceri, Fabio, Müller, Antonia M, Kondo, Takeshi, Teshima, Takanori, Klaeger, Susan, Kuster, Bernhard, Weisdorf, Daniel, van der Velden, Walter, Dörfel, Daniela, Bethge, Wolfgang, Hilgendorf, Inken, Hochhaus, Andreas, Andrieux, Geoffroy, Börries, Melanie, Busch, Hauke, Magenau, John, Reddy, Pavan, Labopin, Myriam, Antin, Joseph H, Henden, Andrea S, Hill, Geoffrey R, Kennedy, Glen A, Bar, Merav, Sarma, Anita, McLornan, Donal, Mufti, Ghulam, Oran, Betul, Rezvani, Katayoun, Shah, Omid, Negrin, Robert S, Nagler, Arnon, Prinz, Marco, Burchert, Andreas, Neubauer, Andreas, Beelen, Dietrich, Mackensen, Andreas, von Bubnoff, Nikolas, Herr, Wolfgang, Becher, Burkhard, Socié, Gerard, Caligiuri, Michael A, Ruggiero, Eliana, Bonini, Chiara, Häcker, Georg, Duyster, Justus, Finke, Jürgen, Pearce, Erika, Blazar, Bruce R, and Zeiser, Robert

Subjects
Interleukin-15 -- Health aspects, Gene mutation -- Health aspects, Sorafenib -- Patient outcomes, Gene expression -- Health aspects, Acute myelocytic leukemia -- Genetic aspects -- Development and progression -- Drug therapy, Biological sciences, Health
Abstract

Individuals with acute myeloid leukemia (AML) harboring an internal tandem duplication (ITD) in the gene encoding Fms-related tyrosine kinase 3 (FLT3) who relapse after allogeneic hematopoietic cell transplantation (allo-HCT) have a 1-year survival rate below 20%. We observed that sorafenib, a multitargeted tyrosine kinase inhibitor, increased IL-15 production by FLT3-ITD[sup.+] leukemia cells. This synergized with the allogeneic CD8[sup.+] T cell response, leading to long-term survival in six mouse models of FLT3-ITD[sup.+] AML. Sorafenib-related IL-15 production caused an increase in CD8[sup.+]CD107a[sup.+]IFN-[gamma][sup.+] T cells with features of longevity (high levels of Bcl-2 and reduced PD-1 levels), which eradicated leukemia in secondary recipients. Mechanistically, sorafenib reduced expression of the transcription factor ATF4, thereby blocking negative regulation of interferon regulatory factor 7 (IRF7) activation, which enhanced IL-15 transcription. Both IRF7 knockdown and ATF4 overexpression in leukemia cells antagonized sorafenib-induced IL-15 production in vitro. Human FLT3-ITD[sup.+] AML cells obtained from sorafenib responders following sorafenib therapy showed increased levels of IL-15, phosphorylated IRF7, and a transcriptionally active IRF7 chromatin state. The mitochondrial spare respiratory capacity and glycolytic capacity of CD8[sup.+] T cells increased upon sorafenib treatment in sorafenib responders but not in nonresponders. Our findings indicate that the synergism of T cells and sorafenib is mediated via reduced ATF4 expression, causing activation of the IRF7-IL-15 axis in leukemia cells and thereby leading to metabolic reprogramming of leukemia-reactive T cells in humans. Therefore, sorafenib treatment has the potential to contribute to an immune-mediated cure of FLT3-ITD-mutant AML relapse, an otherwise fatal complication after allo-HCT., Author(s): Nimitha R Mathew [1, 2]; Francis Baumgartner [1]; Lukas Braun [1]; David O'Sullivan [3]; Simone Thomas [4]; Miguel Waterhouse [1]; Tony A Müller [1]; Kathrin Hanke [1, 2]; Sanaz [...]

Published
2018
Full Text
View/download PDF

115. Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party

Author

Robinson, Stephen P., Boumendil, Ariane, Finel, Herve, Peggs, Karl S., Chevallier, Patrice, Sierra, Jorge, Finke, Jürgen, Poiré, Xavier, Maillard, Natacha, Milpied, Noël, Yakoub-Agha, Ibrahim, Koh, Mickey, Kröger, Nicolaus, Nagler, Arnon, Koc, Yener, Dietrich, Sascha, Montoto, Silvia, and Dreger, Peter

Published
2018
Full Text
View/download PDF

116. Continuously Improving Outcome over Time after Second Allogeneic Stem Cell Transplantation in Relapsed Acute Myeloid Leukemia - a Retrospective Analysis of 1540 Patients on Behalf of the Acute Leukemia Working Party of EBMT

Author

Schmälter, Ann-Kristin, Ngoya, Maud, Finke, Jürgen, Kröger, Nicolaus, Stölzel, Friedrich, Stelljes, Matthias, Valerius, Thomas, Tischer, Johanna, Schröder, Thomas, Dreger, Peter, Blau, Igor Wolfgang, Savani, Bipin, Giebel, Sebastian, Esteve, Jordi, Bazarbachi, Ali, Nagler, Arnon, Schmid, Christoph, Ciceri, Fabio, and Mohty, Mohamad

Subjects
Immunology, ddc:610, Cell Biology, Hematology, Biochemistry
Published
2022

117. Treosulfan compared with <scp>reduced‐intensity</scp> busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial

Author

Beelen, Dietrich, Stelljes, Matthias, Reményi, Péter, Wagner‐Drouet, Eva‐Maria, Dreger, Peter, Bethge, Wolfgang, Ciceri, Fabio, Stölzel, Friedrich, Junghanß, Christian, Labussiere‐Wallet, Hélène, Schaefer‐Eckart, Kerstin, Grigoleit, Goetz U., Scheid, Christof, Patriarca, Francesca, Rambaldi, Alessandro, Niederwieser, Dietger, Hilgendorf, Inken, Russo, Domenico, Socié, Gérard, Holler, Ernst, Glass, Bertram, Casper, Jochen, Wulf, Gerald, Basara, Nadezda, Bieniaszewska, Maria, Stuhler, Gernot, Verbeek, Mareike, La Rocca, Ursula, Finke, Jürgen, Benedetti, Fabio, Pichlmeier, Uwe, Klein, Anja, Baumgart, Joachim, Markiewicz, Miroslaw, and Rocca, Ursula La

Subjects
Leukemia, Myeloid, Acute, Transplantation Conditioning, Myelodysplastic Syndromes, Medizin, Hematopoietic Stem Cell Transplantation, Graft vs Host Disease, Humans, Prospective Studies, Hematology, Middle Aged, Busulfan, Vidarabine, Aged
Abstract

The phase III study was designed to compare event-free survival (EFS) after treosulfan-based conditioning with a widely applied reduced-intensity conditioning (RIC) busulfan regimen in older or comorbid patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) undergoing allogeneic hematopoietic cell transplantation (HCT). A previously reported confirmatory interim analysis of the randomized clinical study including 476 patients demonstrated statistically significant noninferiority for treosulfan with clinically meaningful improvement in EFS. Here, the final study results and pre-specified subgroup analyses of all 570 randomized patients with completed longer-term follow-up are presented. Patients presenting HCT-specific comorbidity index >2 or aged >= 50 years were randomly assigned (1:1) to intravenous (IV) fludarabine with either treosulfan (30 g/m(2) IV) or busulfan (6.4 mg/kg IV) after stratification by disease risk group, donor type, and participating institution. The primary endpoint was EFS with disease recurrence, graft failure, or death from any cause as events. EFS of patients (median age 60 years) was superior after treosulfan compared to RIC busulfan: 36-months-EFS rate 59.5% (95% CI, 52.2-66.1) vs. 49.7% (95% CI, 43.3-55.7) with a hazard ratio (HR) of 0.64 (95% CI, 0.49-0.84), p = 0.0006. Likewise, overall survival (OS) with treosulfan was superior compared to busulfan: 36-month-OS rate 66.8% vs. 56.3%; HR 0.64 (95% CI, 0.48-0.87), p = 0.0037. Post hoc analyses revealed that these differences were consistent with the confirmatory interim analysis, and thereby the treosulfan regimen appears particularly suitable for older AML and MDS patients.

Published
2022

119. Sequential vs Myeloablative vs Reduced Intensity Conditioning for Patients with Myelodysplastic Syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: A Retrospective Study by the Chronic Malignancies Working Party of the EBMT

Author

Potter, Victoria, primary, Gras, Luuk, additional, Biezen, Anja van, additional, Kroeger, Nicolaus, additional, Sockel, Katja, additional, Ganser, Arnold, additional, Finke, Jürgen, additional, labussiere, helene, additional, de Latour, Regis Peffault, additional, Koc, Yener, additional, Friis, Lone, additional, Salmenniemi, Urpu, additional, Jindra, Pavel, additional, Schroeder, Thomas, additional, Tischer, Johanna, additional, Arat, Mutlu, additional, Pascual, María, additional, de Wreede, Liesbeth, additional, Hayden, Patrick, additional, Raj, Kavita, additional, Drozd-solowska, Joanna, additional, Scheid, Christof, additional, McLornan, Donal, additional, Robin, Marie, additional, and Yakoub-Agha, Ibrahim, additional

Published
2023
Full Text
View/download PDF

120. Primary Cancer Matters in Therapy-related Myeloid Neoplasm Patients Receiving Allogeneic Hematopoietic Cell Transplantation: A Study From the Chronic Malignancies Working Party of the EBMT

Author

Robin, Marie, primary, de Wreede, Liesbeth C., additional, Schroeder, Thomas, additional, Stölzel, Friedrich, additional, Kröger, Nicolaus, additional, Koster, Linda, additional, Platzbecker, Uwe, additional, Finke, Jürgen, additional, Ganser, Arnold, additional, Blaise, Didier, additional, Ciceri, Fabio, additional, Maertens, Johan, additional, Labussière Wallet, Hélène, additional, Wang, Junfeng, additional, Chevallier, Patrice, additional, Passweg, Jakob, additional, Cornelissen, Jan J, additional, Nguyen, Stéphanie, additional, Forcade, Edouard, additional, Charbonnier, Amandine, additional, Bonifazi, Francesca, additional, Hayden, Patrick, additional, McLornan, Donal P., additional, and Yakoub-Agha, Ibrahim, additional

Published
2023
Full Text
View/download PDF

121. Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

Author

Ortí, Guillermo, primary, Gras, Luuk, additional, Zinger, Nienke, additional, Finazzi, Maria Chiara, additional, Sockel, Katja, additional, Robin, Marie, additional, Forcade, Edouard, additional, Avenoso, Daniele, additional, Kröger, Nicolaus, additional, Finke, Jürgen, additional, Radujkovic, Aleksandar, additional, Hunault‐Berger, Mathilde, additional, Schroyens, Wilfried, additional, Zuckerman, Tsila, additional, Bourhis, Jean Henri, additional, Chalandon, Yves, additional, Bloor, Adrian, additional, Schots, Rik, additional, de Wreede, Liesbeth C., additional, Drozd‐Sokolowska, Joana, additional, Raj, Kavita, additional, Polverelli, Nicola, additional, Czerw, Tomasz, additional, Hernández‐Boluda, Juan Carlos, additional, McLornan, Donal, additional, and Yakoub‐Agha, Ibrahim, additional

Published
2023
Full Text
View/download PDF

122. Impact of Disease Burden on Clinical Outcomes of AML Patients Receiving Allogeneic Hematopoietic Cell Transplantation: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Author

Bazarbachi, Ali, primary, dalle, iman abou, additional, Labopin, Myriam, additional, schroeder, thomas, additional, Finke, Jürgen, additional, Stelljes, Matthias, additional, neubauer, Andreas, additional, Blaise, Didier, additional, Agha, Ibrahim Yakoub, additional, Salmenniemi, Urpu, additional, Forcade, Edouard, additional, Itälä-Remes, Maija, additional, Dreger, Peter, additional, Bug, Gesine, additional, Heuser, Michael, additional, Choi, Goda, additional, Brissot, Eolia, additional, Giebel, Sebastian, additional, Nagler, Arnon, additional, Ciceri, Fabio, additional, Mohty, Mohamad, additional, Kroeger, Nicolaus, additional, and Passweg, Jakob, additional

Published
2023
Full Text
View/download PDF

123. Comorbidities in recipients of low transplant conditioning intensity regimens for acute myeloid leukemia: an ALWP EBMT study

Author

Fein, Joshua Alexander, primary, Shouval, Roni, additional, Galimard, Jacques-Emmanuel, additional, Labopin, Myriam, additional, Socié, Gerard, additional, Finke, Jürgen, additional, Cornelissen, Jan J, additional, Malladi, Ram, additional, Itälä-Remes, Maija, additional, Chevallier, Patrice, additional, Orchard, Kim, additional, Bunjes, Donald, additional, Aljurf, Mahmoud, additional, Rubio, Marie-Thérèse, additional, Versluis, Jurjen, additional, Mohty, Mohamad, additional, and Nagler, Arnon, additional

Published
2023
Full Text
View/download PDF

124. High-Dose Chemotherapy and Autologous Stem Cell Transplant in Elderly and Fit PCNSL Patients – The Multicenter MARTA Study

Author

Schorb, Elisabeth, primary, Isbell, Lisa Kristina, additional, Kerkhoff, Andrea, additional, Mathas, Stephan, additional, Braulke, Friederike, additional, Egerer, Gerlinde, additional, Röth, Alexander, additional, Schliffke, Simon, additional, Borchmann, Peter, additional, Brunnberg, Uta, additional, Kroschinsky, Frank P., additional, Möhle, Robert, additional, Rank, Andreas, additional, Wellnitz, Dominique, additional, Kasenda, Benjamin, additional, Pospiech, Lisa, additional, Wendler, Julia, additional, Scherer, Florian, additional, Deckert, Martina, additional, Henkes, Elina, additional, von Gottberg, Philipp, additional, Gmehlin, Dennis, additional, Backenstrass, Matthias, additional, Jensch, Antje, additional, Burger-Martin, Elvira, additional, Grishina, Olga, additional, Fricker, Heidi, additional, Malenica, Natalie, additional, Orban, Andras, additional, Duyster, Justus, additional, Ihorst, Gabriele, additional, Finke, Jürgen, additional, and Illerhaus, Gerald, additional

Published
2023
Full Text
View/download PDF

125. Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network

Author

Hermine, Olivier, Hoster, Eva, Walewski, Jan, Bosly, André, Stilgenbauer, Stephan, Thieblemont, Catherine, Szymczyk, Michal, Bouabdallah, Reda, Kneba, Michael, Hallek, Michael, Salles, Gilles, Feugier, Pierre, Ribrag, Vincent, Birkmann, Josef, Forstpointner, Roswitha, Haioun, Corinne, Hänel, Mathias, Casasnovas, René Olivier, Finke, Jürgen, Peter, Norma, Bouabdallah, Kamal, Sebban, Catherine, Fischer, Thomas, Dührsen, Ulrich, Metzner, Bernd, Maschmeyer, Georg, Kanz, Lothar, Schmidt, Christian, Delarue, Richard, Brousse, Nicole, Klapper, Wolfram, Macintyre, Elizabeth, Delfau-Larue, Marie-Hélène, Pott, Christiane, Hiddemann, Wolfgang, Unterhalt, Michael, and Dreyling, Martin

Published
2016
Full Text
View/download PDF

126. High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial

Author

Illerhaus, Gerald, Kasenda, Benjamin, Ihorst, Gabriele, Egerer, Gerlinde, Lamprecht, Monika, Keller, Ulrich, Wolf, Hans-Heinrich, Hirt, Carsten, Stilgenbauer, Stephan, Binder, Mascha, Hau, Peter, Edinger, Matthias, Frickhofen, Norbert, Bentz, Martin, Möhle, Robert, Röth, Alexander, Pfreundschuh, Michael, von Baumgarten, Louisa, Deckert, Martina, Hader, Claudia, Fricker, Heidi, Valk, Elke, Schorb, Elisabeth, Fritsch, Kristina, and Finke, Jürgen

Published
2016
Full Text
View/download PDF

127. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial

Author

Ferreri, Andrés J M, Cwynarski, Kate, Pulczynski, Elisa, Ponzoni, Maurilio, Deckert, Martina, Politi, Letterio S, Torri, Valter, Fox, Christopher P, Rosée, Paul La, Schorb, Elisabeth, Ambrosetti, Achille, Roth, Alexander, Hemmaway, Claire, Ferrari, Angela, Linton, Kim M, Rudà, Roberta, Binder, Mascha, Pukrop, Tobias, Balzarotti, Monica, Fabbri, Alberto, Johnson, Peter, Gørløv, Jette Sønderskov, Hess, Georg, Panse, Jens, Pisani, Francesco, Tucci, Alessandra, Stilgenbauer, Stephan, Hertenstein, Bernd, Keller, Ulrich, Krause, Stefan W, Levis, Alessandro, Schmoll, Hans J, Cavalli, Franco, Finke, Jürgen, Reni, Michele, Zucca, Emanuele, and Illerhaus, Gerald

Published
2016
Full Text
View/download PDF

128. Oncogenic JAK2V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms

Author

Prestipino, Alessandro, Emhardt, Alica J., Aumann, Konrad, O’Sullivan, David, Gorantla, Sivahari P., Duquesne, Sandra, Melchinger, Wolfgang, Braun, Lukas, Vuckovic, Slavica, Boerries, Melanie, Busch, Hauke, Halbach, Sebastian, Pennisi, Sandra, Poggio, Teresa, Apostolova, Petya, Veratti, Pia, Hettich, Michael, Niedermann, Gabriele, Bartholomä, Mark, Shoumariyeh, Khalid, Jutzi, Jonas S., Wehrle, Julius, Dierks, Christine, Becker, Heiko, Schmitt-Graeff, Annette, Follo, Marie, Pfeifer, Dietmar, Rohr, Jan, Fuchs, Sebastian, Ehl, Stephan, Hartl, Frederike A., Minguet, Susana, Miething, Cornelius, Heidel, Florian H., Kröger, Nicolaus, Triviai, Ioanna, Brummer, Tilman, Finke, Jürgen, Illert, Anna L., Ruggiero, Eliana, Bonini, Chiara, Duyster, Justus, Pahl, Heike L., Lane, Steven W., Hill, Geoffrey R., Blazar, Bruce R., von Bubnoff, Nikolas, Pearce, Erika L., and Zeiser, Robert

Published
2018
Full Text
View/download PDF

129. 10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial

Author

Lübbert, Michael, Wijermans, Pierre W, Kicinski, Michal, Chantepie, Sylvain, Van der Velden, Walter J F M, Noppeney, Richard, Griškevičius, Laimonas, Neubauer, Andreas, Crysandt, Martina, Vrhovac, Radovan, Luppi, Mario, Fuhrmann, Stephan, Audisio, Ernesta, Candoni, Anna, Legrand, Olivier, Foà, Robin, Gaidano, Gianluca, van Lammeren-Venema, Danielle, Posthuma, Eduardus F M, Hoogendoorn, Mels, Giraut, Anne, Stevens-Kroef, Marian, Jansen, Joop H, de Graaf, Aniek O, Efficace, Fabio, Ammatuna, Emanuele, Vilque, Jean-Pierre, Wäsch, Ralph, Becker, Heiko, Blijlevens, Nicole, Dührsen, Ulrich, Baron, Frédéric, Suciu, Stefan, Amadori, Sergio, Venditti, Adriano, Huls, Gerwin, Finke, Jürgen, Schaap, Nicolaas Petrus Michael, Zucenka, Andrius, Metzelder, Stephan, Jost, Edgar, Perić, Zinaida, Forghieri, Fabio, Allione, Bernadino, Martelli, Maurizio, Iori, Anna Paola, Wittnebel, Sebastian, Mengarelli, Andrea, Imovilli, Annalisa, Olivieri, Attilio, De Prijck, Bernard José Marie, van der Poel, Marjolein W.M., Junghanß, Christian, Salih, Helmut Rainer, Tafuri, Agostino, Guimarães, José Eduardo, Musso, Maurizio, De Fabritiis, Paolo, Chevallier, Patrice, Selleslag, Dominik Luc, Cascavilla, Nicola, Berneman, Zwi, Jaspers, Aurélie, Zuffa, Eliana, Vanstraelen, Gaëtan, Visani, Giuseppe, Cuijpers, Maria Louisa Henriëtte, De Becker, Ann, Mianulli, Anna Maria, Hackanson, Björn, Mihaylov, Georgi Georgiev, Martinelli, Giovanni, Paolini, Stefania, Zinzani, Pier Luigi, Henkes, Martin, Al-Ali, Haifa Kathrin, La Rosée, Paul, Chierichini, Anna, Cudillo, Laura, Specchia, Giorgina, Šimec, Njetočka Gredelj, Capalbo, Silvana Franca, Spinosa, Giuseppina, Molica, Stefano, and de Jonge-Peeters, Susan Dorothé

Abstract

Many older patients with acute myeloid leukaemia die or cannot undergo allogeneic haematopoietic stem-cell transplantation (HSCT) due to toxicity caused by intensive chemotherapy. We hypothesised that replacing intensive chemotherapy with decitabine monotherapy could improve outcomes.

Published
2023
Full Text
View/download PDF

130. Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT

Author

Noviello, Maddalena, Manfredi, Francesco, Ruggiero, Eliana, Perini, Tommaso, Oliveira, Giacomo, Cortesi, Filippo, De Simone, Pantaleo, Toffalori, Cristina, Gambacorta, Valentina, Greco, Raffaella, Peccatori, Jacopo, Casucci, Monica, Casorati, Giulia, Dellabona, Paolo, Onozawa, Masahiro, Teshima, Takanori, Griffioen, Marieke, Halkes, Constantijn J. M., Falkenburg, J. H. F., Stölzel, Friedrich, Altmann, Heidi, Bornhäuser, Martin, Waterhouse, Miguel, Zeiser, Robert, Finke, Jürgen, Cieri, Nicoletta, Bondanza, Attilio, Vago, Luca, Ciceri, Fabio, and Bonini, Chiara

Published
2019
Full Text
View/download PDF

134. Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency

Author

Wehr, Claudia, Gennery, Andrew R., Lindemans, Caroline, Schulz, Ansgar, Hoenig, Manfred, Marks, Reinhard, Recher, Mike, Gruhn, Bernd, Holbro, Andreas, Heijnen, Ingmar, Meyer, Deborah, Grigoleit, Goetz, Einsele, Hermann, Baumann, Ulrich, Witte, Thorsten, Sykora, Karl-Walter, Goldacker, Sigune, Regairaz, Lorena, Aksoylar, Serap, Ardeniz, Ömur, Zecca, Marco, Zdziarski, Przemyslaw, Meyts, Isabelle, Matthes-Martin, Susanne, Imai, Kohsuke, Kamae, Chikako, Fielding, Adele, Seneviratne, Suranjith, Mahlaoui, Nizar, Slatter, Mary A., Güngör, Tayfun, Arkwright, Peter D., van Montfrans, Joris, Sullivan, Kathleen E., Grimbacher, Bodo, Cant, Andrew, Peter, Hans-Hartmut, Finke, Juergen, Gaspar, H. Bobby, Warnatz, Klaus, and Rizzi, Marta

Published
2015
Full Text
View/download PDF

135. Comparison of Unrelated Cord Blood and Peripheral Blood Stem Cell Transplantation in Adults with Myelodysplastic Syndrome after Reduced-Intensity Conditioning Regimen: A Collaborative Study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working Party

Author

Robin, Marie, Ruggeri, Annalisa, Labopin, Myriam, Niederwieser, Dietger, Tabrizi, Reza, Sanz, Guillermo, Bourhis, Jean-Henri, van Biezen, Anja, Koenecke, Christian, Blaise, Didier, Tischer, Johanna, Craddock, Charles, Maillard, Natacha, Mohty, Mohamad, Russel, Nigel, Schetelig, Johannes, Finke, Jürgen, Gluckman, Eliane, de Witte, Theo M., Rocha, Vanderson, and Kroger, Nicolaus

Published
2015
Full Text
View/download PDF

136. Retrospective analysis of hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: conditioning intensity matters

Author

Bruch, Peter-Martin, primary, Dietrich, Sascha, additional, Finel, Herve, additional, Boumendil, Ariane, additional, Greinix, Hildegard, additional, Heinicke, Thomas, additional, Bethge, Wolfgang, additional, Beelen, Dietrich, additional, Schmid, Christoph, additional, Martin, Hans, additional, Castagna, Luca, additional, Scheid, Christof, additional, Schäfer-Eckart, Kerstin, additional, Bittenbring, Jörg, additional, Finke, Jürgen, additional, Sengeloev, Henrik, additional, Heiblig, Mael, additional, Cornelissen, Jan, additional, Chevallier, Patrice, additional, Mohty, Mohamad, additional, Robinson, Stephen, additional, Montoto, Silvia, additional, and Dreger, Peter, additional

Published
2022
Full Text
View/download PDF

137. Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma

Author

Keppler-Hafkemeyer, Andrea, primary, Greil, Christine, additional, Wratil, Paul R., additional, Shoumariyeh, Khalid, additional, Stern, Marcel, additional, Hafkemeyer, Annika, additional, Ashok, Driti, additional, Hollaus, Alexandra, additional, Lupoli, Gaia, additional, Priller, Alina, additional, Bischof, Marie L., additional, Ihorst, Gabriele, additional, Engelhardt, Monika, additional, Marks, Reinhard, additional, Finke, Jürgen, additional, Bertrand, Hannah, additional, Dächert, Christopher, additional, Muenchhoff, Maximilian, additional, Badell, Irina, additional, Emmerich, Florian, additional, Halder, Hridi, additional, Spaeth, Patricia M., additional, Knolle, Percy A., additional, Protzer, Ulrike, additional, von Bergwelt-Baildon, Michael, additional, Duyster, Justus, additional, Hartmann, Tanja N., additional, Moosmann, Andreas, additional, and Keppler, Oliver T., additional

Published
2022
Full Text
View/download PDF

138. Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas

Author

Mutter, Jurik A., primary, Alig, Stefan K., additional, Esfahani, Mohammad S., additional, Lauer, Eliza M., additional, Mitschke, Jan, additional, Kurtz, David M., additional, Kühn, Julia, additional, Bleul, Sabine, additional, Olsen, Mari, additional, Liu, Chih Long, additional, Jin, Michael C., additional, Macaulay, Charles W., additional, Neidert, Nicolas, additional, Volk, Timo, additional, Eisenblaetter, Michel, additional, Rauer, Sebastian, additional, Heiland, Dieter H., additional, Finke, Jürgen, additional, Duyster, Justus, additional, Wehrle, Julius, additional, Prinz, Marco, additional, Illerhaus, Gerald, additional, Reinacher, Peter C., additional, Schorb, Elisabeth, additional, Diehn, Maximilian, additional, Alizadeh, Ash A., additional, and Scherer, Florian, additional

Published
2022
Full Text
View/download PDF

139. Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)

Author

Illerhaus, Gerald, primary, Ferreri, Andrés J.M., additional, Binder, Mascha, additional, Borchmann, Peter, additional, Hasenkamp, Justin, additional, Stilgenbauer, Stephan, additional, Roeth, Alexander, additional, Weber, Thomas, additional, Egerer, Gerlinde, additional, Ernst, Thomas, additional, Hertenstein, Bernd, additional, Lenz, Georg, additional, Kobbe, Guido, additional, Brunnberg, Uta, additional, Schmidt, Christian, additional, Kneba, Michael, additional, Dreyling, Martin, additional, Möhle, Robert, additional, Panse, Jens, additional, Heinicke, Thomas, additional, Schroll, Sebastian, additional, Larsen, Thomas S., additional, Salwender, Hans, additional, Naumann, Ralph, additional, Hess, Georg, additional, Thurner, Lorenz, additional, Pukrop, Tobias, additional, Keller, Ulrich, additional, Blystadt, Anne Kirsti, additional, Kroschinsky, Frank P., additional, Re, Francesca, additional, Pulczynski, Elisa, additional, Orsucci, Lorella, additional, Pospiech, Lisa, additional, Deckert, Martina, additional, Ponzoni, Maurilio, additional, Wendler, Julia, additional, Valk, Elke, additional, Calimeri, Teresa, additional, Kasenda, Benjamin, additional, Trepel, Martin, additional, Fricker, Heidi, additional, von Gottberg, Philipp, additional, Burger, Elvira, additional, Ihorst, Gabriele, additional, Grishina, Olga, additional, Hader, Claudia, additional, Zucca, Emanuele, additional, Finke, Jürgen, additional, and Schorb, Elisabeth, additional

Published
2022
Full Text
View/download PDF

141. Comparison of Fludarabine/Melphalan (FluMel) with Fludarabine/Melphalan/BCNU or Thiotepa (FBM/FTM) in Patients with AML in First Complete Remission Undergoing Allogeneic Hematopoietic Stem Cell Transplantation - a Registry Study on Behalf of the EBMT Acute Leukemia Working Party

Author

Duque Afonso, Jesus, primary, Finke, Jürgen, additional, Ngoya, Maud, additional, Galimard, Jacques-Emmanuel, additional, Craddock, Charles, additional, Raj, Kavita, additional, Bloor, Adrian, additional, Nicholson, Emma, additional, Eder, Matthias, additional, Orchard, Kim H., additional, Valerius, Thomas, additional, Snowden, John A., additional, Tholouli, Eleni, additional, Crawley, Charles, additional, Collin, Matthew P., additional, Wilson, Keith, additional, Gadisseur, Alain, additional, Protheroe, Rachel Elizabeth, additional, Wagner, Eva Maria, additional, Savani, Bipin, additional, Spyridonidis, Alexandros, additional, Ciceri, Fabio, additional, Nagler, Arnon, additional, and Mohty, Mohamad, additional

Published
2022
Full Text
View/download PDF

142. Allogeneic Hematopoietic Cell Transplantation in Patients with Therapy-Related Myeloid Neoplasm Following Treatment for Lymphoma: A Study of the Chronic Malignancies Working Party of the EBMT

Author

Nabergoj, Mitja, primary, Eikema, Dirk-Jan, additional, Zinger, Nienke, additional, Platzbecker, Uwe, additional, Sockel, Katja, additional, Finke, Jürgen, additional, Kröger, Nicolaus, additional, Forcade, Edouard, additional, Nagler, Arnon, additional, Ganser, Arnold, additional, Tischer, Johanna, additional, Broers, Annoek E.C., additional, Kuball, Jurgen, additional, Wilson, Keith, additional, Mathilde, Hunault-Berger, additional, Collin, Matthew P., additional, Russo, Domenico, additional, Pérez López, Estefanía, additional, Helbig, Grzegorz, additional, Mussetti, Alberto, additional, Raj, Kavita, additional, Scheid, Christof, additional, McLornan, Donal P., additional, Robin, Marie, additional, and Yakoub-Agha, Ibrahim, additional

Published
2022
Full Text
View/download PDF

143. Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in Patients with Calr-Mutated Myelofibrosis

Author

Hernandez Boluda, Juan Carlos, primary, Eikema, Dirk-Jan, additional, Erazo, Nadia, additional, Kröger, Nicolaus, additional, Robin, Marie, additional, de Witte, Moniek, additional, Finke, Jürgen, additional, Rambaldi, Alessandro, additional, Broers, Annoek E.C., additional, Raida, Ludek, additional, Schaap, Nicolaas, additional, Chiusolo, Patrizia, additional, Verbeek, Mareike, additional, Choi, Goda, additional, Halaburda, Kazimierz, additional, Kulagin, Alexander D., additional, Labussiere-Wallet, Helene, additional, Gedde-Dahl, Tobias, additional, Rabitsch, Werner, additional, Raj, Kavita, additional, Drozd-Sokolowska, Joanna, additional, Polverelli, Nicola, additional, Czerw, Tomasz, additional, Yakoub-Agha, Ibrahim, additional, and McLornan, Donal P., additional

Published
2022
Full Text
View/download PDF

144. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation from Different Donor Types in Primary Refractory Acute Myeloid Leukemia: A Report from the ALWP of the EBMT

Author

Barbullushi, Kordelia, primary, Labopin, Myriam, additional, Kröger, Nicolaus, additional, Finke, Jürgen, additional, Stelljes, Matthias, additional, Ganser, Arnold, additional, Bethge, Wolfgang, additional, Einsele, Hermann, additional, Schetelig, Johannes, additional, Fanin, Renato, additional, Jindra, Pavel, additional, Casper, Jochen, additional, Schroeder, Thomas, additional, Edinger, Matthias, additional, Passweg, Jakob, additional, Forcade, Edouard, additional, Tischer, Johanna, additional, Nagler, Arnon, additional, Ciceri, Fabio, additional, and Mohty, Mohamad, additional

Published
2022
Full Text
View/download PDF

145. Outcomes of Allogeneic Haematopoietic Stem Cell Transplantation for Therapy-Related Myeloid Neoplasms Following Treatment for Myeloma

Author

Lawless, Sarah, primary, Morris, Curly, additional, Eikema, Dirk-Jan, additional, Kostner, Linda, additional, Stoelzel, Friedrich, additional, Kröger, Nicolaus, additional, Platzbecker, Uwe, additional, Bethge, Wolfgang, additional, Brossart, Peter, additional, Fanin, Renato, additional, Finke, Jürgen, additional, Kuball, Jurgen, additional, Leblond, Veronique, additional, Nicholson, Emma, additional, Passweg, Jakob, additional, Avenoso, Daniele, additional, Bay, Jacques-Olivier, additional, Bazarbachi, Ali, additional, Caballero, Dolores, additional, Drozd-Sokolowska, Joanna, additional, Scheid, Christof, additional, McLornan, Donal P., additional, Robin, Marie, additional, and Yakoub-Agha, Ibrahim, additional

Published
2022
Full Text
View/download PDF

146. CART Therapy or Allogeneic Stem Cell Transplantation in ≥ Third Line Treatment of Large B Cell Lymphoma (LBCL)

Author

Glass, Bertram, primary, Sureda, Anna, additional, Boumendil, Ariane, additional, Dreger, Peter, additional, Corradini, Paolo, additional, Ram, Ron, additional, Kroeger, Nicolaus, additional, Castagna, Luca, additional, Pabst, Thomas, additional, Kwon, Mi, additional, Wulf, Gerald, additional, Martín García-Sancho, Alejandro, additional, Solano, Carlos, additional, Stelljes, Matthias, additional, Reinhardt, Hans Christian, additional, Rubio, Marie Thérèse, additional, Malladi, Ram, additional, Blaise, Didier, additional, Besley, Caroline, additional, Forcade, Edouard, additional, von Bonin, Malte, additional, Finke, Jürgen, additional, Hilgendorf, Inken, additional, Martínez-López, Joaquín, additional, Perez-Simon, Jose A., additional, Bethge, Wolfgang, additional, and Schmitz, Norbert, additional

Published
2022
Full Text
View/download PDF

147. Registry Data Indicate a Meaningful Chance for Successful Pregnancies after Allogeneic Stem Cell Transplantation: Results from the German Stem Cell Transplant Registry (DRST)

Author

Sockel, Katja, primary, Frank, Sandra, additional, Neu, Annika, additional, Ditschkowski, Markus, additional, Hilgendorf, Inken, additional, Goeckenjan, Mareen, additional, Stoelzel, Friedrich, additional, Middeke, Jan Moritz, additional, Kröger, Nicolaus, additional, Ayuk, Francis A., additional, Eder, Matthias, additional, Bethge, Wolfgang, additional, Finke, Jürgen, additional, Bertz, Hartmut, additional, Kobbe, Guido, additional, Kaufmann, Martin, additional, Platzbecker, Uwe, additional, Beverungen, David, additional, Schmid, Christoph, additional, von Bonin, Malte, additional, Egger-Heidrich, Katharina, additional, Heberling, Lisa, additional, Trautmann-Grill, Karolin, additional, Teipel, Raphael, additional, Bug, Gesine, additional, Tischer, Johanna, additional, Fraccaroli, Alessia, additional, Holler, Barbara, additional, Wolff, Daniel, additional, Luft, Thomas, additional, Roesler, Wolf, additional, Schäfer-Eckart, Kerstin, additional, Dressler, Sabine, additional, Scheid, Christof, additional, Holtick, Udo, additional, Klein, Stefan, additional, Blau, Igor Wolfgang, additional, Burchert, Andreas, additional, Wulf, Gerald, additional, Hasenkamp, Justin, additional, Schwerdtfeger, Rainer, additional, Kaun, Stephan, additional, Wittke, Christoph, additional, Wortmann, Friederike, additional, Neidlinger, Helga, additional, Bornhaeuser, Martin, additional, Schetelig, Johannes, additional, and of the German Cooperative Transplant Study Group, on Behalf, additional

Published
2022
Full Text
View/download PDF

148. High-Dose Chemotherapy and Autologous Stem Cell Transplant in Elderly and Fit Primary CNS Lymphoma Patients - a Multicenter Study By the Cooperative PCNSL Study Group (MARTA study)

Author

Schorb, Elisabeth, primary, Isbell, Lisa, additional, Kerkhoff, Andrea, additional, Mathas, Stephan, additional, Braulke, Friederike, additional, Egerer, Gerlinde, additional, Roeth, Alexander, additional, Schliffke, Simon Christian, additional, Borchmann, Peter, additional, Brunnberg, Uta, additional, Kroschinsky, Frank P., additional, Möhle, Robert, additional, Rank, Andreas, additional, Wellnitz, Dominique, additional, Kasenda, Benjamin, additional, Pospiech, Lisa, additional, Wendler, Julia, additional, Ihorst, Gabriele, additional, Scherer, Florian, additional, Deckert, Martina, additional, Henkes, Elina, additional, Duyster, Justus, additional, Finke, Jürgen, additional, and Illerhaus, Gerald, additional

Published
2022
Full Text
View/download PDF

149. Trends in the Use of Hematopoietic Stem Cell Transplantation in the Management of Relapsed/Refractory Diffuse Large B Cell Lymphoma. a Retrospective Analysis of the Lymphoma Working Party of the EBMT

Author

Sureda, Anna, primary, Boumendil, Ariane, additional, Berning, Philipp, additional, Finel, Hervé, additional, Caillot, Denis, additional, Roesler, Wolf, additional, Finke, Jürgen, additional, Blau, Igor Wolfgang, additional, Leblond, Veronique, additional, Bittenbring, Joerg, additional, Tsoulkani, Anna, additional, Carpenter, Ben, additional, Nagler, Arnon, additional, Blaise, Didier, additional, Dreger, Peter, additional, and Schmitz, Norbert, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results